INSIGHTS ON DRUG DEVELOPMENT

• Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics

  Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.

• Denaturing SEC-MS Analysis Of High Molecular Weight Impurities

  Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.

• Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development

  The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.

• Ask Us Anything: Anmaris Torres On The First Steps In Process Transfer

  Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.

• 3 Key Considerations In Gene Therapy Manufacturing

  7/15/2025

  Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

• SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds

  8/20/2026

  Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

• Using Residual DNA Quantification Data To De-Risk mAb Development

  6/11/2026

  Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

• Ask Us Anything: Daniele Vigo On Cost-Effective Process Development

  7/23/2026

  Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.

• Why Pharmaceutical Scientists Trust The Discovery Core Rheometer

  5/1/2026

  Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.